<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Krichardsondo</id>
	<title>WikEM - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Krichardsondo"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/wiki/Special:Contributions/Krichardsondo"/>
	<updated>2026-05-14T00:30:53Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8080</id>
		<title>Primary sclerosing cholangitis</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8080"/>
		<updated>2012-02-21T23:03:47Z</updated>

		<summary type="html">&lt;p&gt;Krichardsondo: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Primary Sclerosing Cholangitis (PSC) &lt;br /&gt;
&lt;br /&gt;
== Background  ==&lt;br /&gt;
&lt;br /&gt;
Autoimmune Dz typically seen in young men &lt;br /&gt;
&lt;br /&gt;
Progressive inflammation and fibrosis of intra/extra hepatic bile ducts &lt;br /&gt;
&lt;br /&gt;
Most (80%) cases are associated with inflammatory bowel dz, typically ulcerative colitis, 10% of pts with ulcerative colitis have PSC &lt;br /&gt;
&lt;br /&gt;
Increased risk of colon CA in pts with Ulcerative colitis and PSC (more than UC alone) Increased risk of cholangiocarcinoma &lt;br /&gt;
&lt;br /&gt;
Prevalence is 1 to 6 per 100,000 in the U.S &lt;br /&gt;
&lt;br /&gt;
== Clinical Features  ==&lt;br /&gt;
&lt;br /&gt;
Generally asymptomatic but can present with fatigue, abd pain, jaundice, cholangitis, puritis, weight loss, or fever &lt;br /&gt;
&lt;br /&gt;
Mean age at presentation: 30-40&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
== Diagnosis&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Cholangiography &lt;br /&gt;
&lt;br /&gt;
Dx made by ERCP or MRCP, which demonstrates strictures or beading of the intrahepatic or extrahepatic bile ducts &lt;br /&gt;
&lt;br /&gt;
Liver biopsy typically shows pericholangitis and periductual fibrosis but is often not diagnostic in early dz &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Work-Up&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Alkaline phosphatase is usually elevated with mild elevations in aminotransferases &lt;br /&gt;
&lt;br /&gt;
Bilirubin is typically normal, except when common hepatic duct or common bile duct is involved in late stages of dz &lt;br /&gt;
&lt;br /&gt;
Perinuclear antineutrophil cytoplasmic antibody (pANCA) positive in 2/3rds of cases &lt;br /&gt;
&lt;br /&gt;
== DDx  ==&lt;br /&gt;
&lt;br /&gt;
== Treatment  ==&lt;br /&gt;
&lt;br /&gt;
High dose Ursodeoxycholic acid (UDCA), 25-30mg/kg/day, may improve liver chemistries but does not slow dz progression and may actually hasten development of portal HTN &lt;br /&gt;
&lt;br /&gt;
Periodic dilation of strictures via ERCP or percutaneous route &lt;br /&gt;
&lt;br /&gt;
Liver Transplant should be offered to those with advanced liver dz or repeated bouts of cholangitis (Dz can recur after transplantation) &lt;br /&gt;
&lt;br /&gt;
== Disposition  ==&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;Annual Screening for colon cancer in pts with concomitant UC &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
== See Also  ==&lt;br /&gt;
&lt;br /&gt;
== Source&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Current Clinical Medicine, 2nd edition by Cleveland Clinic &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:GI]]&lt;/div&gt;</summary>
		<author><name>Krichardsondo</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8079</id>
		<title>Primary sclerosing cholangitis</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8079"/>
		<updated>2012-02-21T23:00:28Z</updated>

		<summary type="html">&lt;p&gt;Krichardsondo: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Primary Sclerosing Cholangitis (PSC) &lt;br /&gt;
&lt;br /&gt;
== Background  ==&lt;br /&gt;
&lt;br /&gt;
Autoimmune Dz typically seen in young men &lt;br /&gt;
&lt;br /&gt;
Progressive inflammation and fibrosis of intra/extra hepatic bile ducts &lt;br /&gt;
&lt;br /&gt;
Most (80%) cases are associated with inflammatory bowel dz, typically ulcerative colitis, 10% of pts with ulcerative colitis have PSC &lt;br /&gt;
&lt;br /&gt;
Increased risk of colon CA in pts with Ulcerative colitis and PSC (more than UC alone) Increased risk of cholangiocarcinoma &lt;br /&gt;
&lt;br /&gt;
Prevalence is 1 to 6 per 100,000 in the U.S &lt;br /&gt;
&lt;br /&gt;
== Clinical Features  ==&lt;br /&gt;
&lt;br /&gt;
Generally asymptomatic but can present with fatigue, abd pain, jaundice, cholangitis, puritis, weight loss, or fever &lt;br /&gt;
&lt;br /&gt;
Mean age at presentation: 30-40&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
== Diagnosis&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Cholangiography &lt;br /&gt;
&lt;br /&gt;
Dx made by ERCP or MRCP, which demonstrates strictures or beading of the intrahepatic or extrahepatic bile ducts &lt;br /&gt;
&lt;br /&gt;
Liver biopsy typically shows pericholangitis and periductual fibrosis but is often not diagnostic in early dz &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Work-Up&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Alkaline phosphatase is usually elevated with mild elevations in aminotransferases &lt;br /&gt;
&lt;br /&gt;
Bilirubin is typically normal, except when common hepatic duct or common bile duct is involved in late stages of dz &lt;br /&gt;
&lt;br /&gt;
Perinuclear antineutrophil cytoplasmic antibody (pANCA) positive in 2/3rds of cases &lt;br /&gt;
&lt;br /&gt;
== DDx  ==&lt;br /&gt;
&lt;br /&gt;
== Treatment  ==&lt;br /&gt;
&lt;br /&gt;
High dose Ursodeoxycholic acid (UDCA), 25-30mg/kg/day, may improve liver chemistries but does not slow dz progression and may actually hasten development of portal HTN &lt;br /&gt;
&lt;br /&gt;
Periodic dilation of strictures via ERCP or percutaneous route &lt;br /&gt;
&lt;br /&gt;
Liver Transplant should be offered to those with advanced liver dz or repeated bouts of cholangitis (Dz can recur after transplantation) &lt;br /&gt;
&lt;br /&gt;
== Disposition  ==&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;Annual Screening for colon cancer in pts with concomitant UC &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
== See Also  ==&lt;br /&gt;
&lt;br /&gt;
== Source&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Current Clinical Medicine, 2nd edition by Cleveland Clinic&lt;/div&gt;</summary>
		<author><name>Krichardsondo</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=User:Krichardsondo&amp;diff=8078</id>
		<title>User:Krichardsondo</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=User:Krichardsondo&amp;diff=8078"/>
		<updated>2012-02-21T22:42:51Z</updated>

		<summary type="html">&lt;p&gt;Krichardsondo: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Kris Richardson DO. &lt;br /&gt;
&lt;br /&gt;
 PGY4 EM/IM&lt;br /&gt;
 Mclaren Oakland Hospital&lt;/div&gt;</summary>
		<author><name>Krichardsondo</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8077</id>
		<title>Primary sclerosing cholangitis</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8077"/>
		<updated>2012-02-21T22:41:17Z</updated>

		<summary type="html">&lt;p&gt;Krichardsondo: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Primary Sclerosing Cholangitis (PSC) &lt;br /&gt;
&lt;br /&gt;
== Background  ==&lt;br /&gt;
&lt;br /&gt;
Autoimmune Dz typically seen in young men &lt;br /&gt;
&lt;br /&gt;
Progressive inflammation and fibrosis of intra/extra hepatic bile ducts &lt;br /&gt;
&lt;br /&gt;
Most (80%) cases are associated with inflammatory bowel dz, typically ulcerative colitis, 10% of pts with ulcerative colitis have PSC &lt;br /&gt;
&lt;br /&gt;
Increased risk of colon CA in pts with Ulcerative colitis and PSC (more than UC alone) Increased risk of cholangiocarcinoma Prevalence is 1 to 6 per 100,000 in the U.S &lt;br /&gt;
&lt;br /&gt;
== Clinical Features  ==&lt;br /&gt;
&lt;br /&gt;
Generally asymptomatic but can present with fatigue, abd pain, jaundice, cholangitis, puritis, weight loss, or fever&lt;br /&gt;
&lt;br /&gt;
Mean age at presentation: 30-40&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
== Diagnosis&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Cholangiography&lt;br /&gt;
&lt;br /&gt;
Dx made by ERCP or MRCP, which demonstrates strictures or beading of the intrahepatic or extrahepatic bile ducts &lt;br /&gt;
&lt;br /&gt;
Liver biopsy typically shows pericholangitis and periductual fibrosis but is often not diagnostic in early dz &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Work-Up&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Alkaline phosphatase is usually elevated with mild elevations in aminotransferases&lt;br /&gt;
&lt;br /&gt;
Bilirubin is typically normal, except when common hepatic duct or common bile duct is involved and in late stages of dz&lt;br /&gt;
&lt;br /&gt;
Perinuclear antineutrophil cytoplasmic antibody (pANCA) positive in 2/3rds of cases&lt;br /&gt;
&lt;br /&gt;
== DDx  ==&lt;br /&gt;
&lt;br /&gt;
== Treatment  ==&lt;br /&gt;
&lt;br /&gt;
High dose Ursodeoxycholic acid (UDCA), 25-30mg/kg/day, may improve liver chemistries but does not slow dz progression and may actually hasten development of portal HTN &lt;br /&gt;
&lt;br /&gt;
Periodic dilation of strictures via ERCP or percutaneous route &lt;br /&gt;
&lt;br /&gt;
Liver Transplant should be offered to those with advanced liver dz or repeated bouts of cholangitis (Dz can recur after transplantation) &lt;br /&gt;
&lt;br /&gt;
== Disposition  ==&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;Annual Screening for colon cancer in pts with concomitant UC &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
== See Also  ==&lt;br /&gt;
&lt;br /&gt;
== Source&amp;lt;br&amp;gt;  ==&lt;br /&gt;
&lt;br /&gt;
Current Clinical Medicine, 2nd edition by Cleveland Clinic&lt;/div&gt;</summary>
		<author><name>Krichardsondo</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8076</id>
		<title>Primary sclerosing cholangitis</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Primary_sclerosing_cholangitis&amp;diff=8076"/>
		<updated>2012-02-21T22:32:19Z</updated>

		<summary type="html">&lt;p&gt;Krichardsondo: Created page with &amp;quot;Primary Sclerosing Cholangitis (PSC)  == Background  ==  Autoimmune Dz typically seen in young men  Progressive inflammatory destruction of medium and large bile ducts  Most (80%...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Primary Sclerosing Cholangitis (PSC)&lt;br /&gt;
&lt;br /&gt;
== Background  ==&lt;br /&gt;
&lt;br /&gt;
Autoimmune Dz typically seen in young men&lt;br /&gt;
&lt;br /&gt;
Progressive inflammatory destruction of medium and large bile ducts&lt;br /&gt;
&lt;br /&gt;
Most (80%) cases are associated with inflammatory bowel dz, typically ulcerative colitis 10% of pts with ulcerative colitis have PSC&lt;br /&gt;
&lt;br /&gt;
Increased risk of colon CA in pts with Ulcerative colitis and PSC (more than UC alone) Increased risk of cholangiocarcinoma Prevalence is 1 to 6 per 100,000 in the U.S&lt;br /&gt;
&lt;br /&gt;
== Clinical Features  ==&lt;br /&gt;
&lt;br /&gt;
Generally asymptomatic but can present with abd pain, jaundice, cholangitis, or puritis&lt;br /&gt;
&lt;br /&gt;
Mean age at presentation: 30-40&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Diagnosis&amp;lt;br&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
Alkaline phosphatase is usually elevated with mild elevations in aminotransferases&lt;br /&gt;
&lt;br /&gt;
Bilirubin is typically normal, except when common hepatic duct or common bile duct is involved and in late stages of dz &lt;br /&gt;
&lt;br /&gt;
Dx made by ERCP or MRCP, which demonstrates strictures or beading of the intrahepatic or extrahepatic bile ducts&lt;br /&gt;
&lt;br /&gt;
Liver biopsy typically shows pericholangitis and periductual fibrosis but is often not diagnostic in early dz &lt;br /&gt;
&lt;br /&gt;
Perinuclear antineutrophil cytoplasmic antibody (pANCA) positive in 2/3rds of cases&lt;br /&gt;
&lt;br /&gt;
== Work-Up&amp;lt;br&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
== DDx ==&lt;br /&gt;
&lt;br /&gt;
== Treatment  ==&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;High dose Ursodeoxycholic acid (UDCA), 25-28mg/kg/day, may improve liver chemistries but does not slow dz progression and may actually hasten development of portal HTN&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;Periodic dilation of strictures via ERCP or percutaneous route&lt;br /&gt;
&lt;br /&gt;
Liver Transplant should be offered to those with advanced liver dz or repeated bouts of cholangitis (Dz can recur after transplantation)&lt;br /&gt;
&lt;br /&gt;
== Disposition  ==&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;Annual Screening for colon cancer pts with concomitant UC&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== See Also  ==&lt;br /&gt;
&lt;br /&gt;
== Source&amp;lt;br&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Krichardsondo</name></author>
	</entry>
</feed>